Drug Trial Radar · NCT00589914
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
Last checked: Nov 19, 2026Latest source record: Jun 24, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,221
Actual
Start
Mar 2007
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Johnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jan 10, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the effectiveness of paliperidone palmitate in patients with Schizophrenia.
Conditions
- Schizophrenia
Interventions
RISPERDAL CONSTADrug
RISPERDAL CONSTA: Type=exact number, unit=mg, number=25, 37.5, or 50, form=suspension for injection, route=Intramuscular use. One i.m. injection of RISPERDAL CONSTA 25-50 mg eq every 2 weeks at V4, V6, V7, V8, V9, and V10. PALIPERIDONE PALMITATE PLACEBO: Form=suspension for injection, route=Intramuscular use. One i.m. injection every 2 weeks at Baseline and at V4, V7, and V9. RISPERIDONE: Type=up to, unit=mg, number=1 to 6, form=Tablet, route=Oral Use. One tablet for the first 4 weeks (28 days) of the DB treatment period.
Paliperidone palmitateDrug
PALIPERIDONE PALMITATE: Type=exact number, unit=mg, number=50, 100, or 150, form=suspension for injection, route=Intramuscular use. One i.m. injection of Paliperidone palmitate 50-150 mg eq every 4 wks at Baseline, V4, V7, and V9. RISPERDAL CONSTA PLACEBO: Form=suspension for injection, route=Intramuscular use. One i.m. injection every 4 weeks at Baseline, V4, V7, and V9.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the Positive and Negative Syndrome Scale (PANSS) Total Score for SchizophreniaTime frame: Baseline to the last postrandomization assessment in the double-blind treatment period (approximately 13 weeks)
Locations
82 sites in 14 countries. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Little Rock, Arkansas
Site not named
Cerritos, California
Site not named
Garden Grove, California
Site not named
Los Angeles, California
Site not named
Washington D.C., District of Columbia
Site not named
Atlanta, Georgia
Site not named
Chicago, Illinois
Site not named
Flowood, Mississippi
Site not named
Hollis, New York
Site not named
Willoughby, Ohio
Site not named
Oklahoma City, Oklahoma
Site not named
DeSoto, Texas
Site not named
Houston, Texas
Site not named
Odessa, Texas
Site not named
Linz, Austria
Site not named
Salzburg, Austria
Site not named
Vienna, Austria
Site not named
Plovdiv, Bulgaria
Site not named
Varna, Bulgaria
Site not named
Brno, Czechia
Site not named
Dobřany, Czechia
Site not named
Kroměříž, Czechia
Site not named
Kutná Hora, Czechia
Site not named
Olomouc, Czechia
Site not named
Prague, Czechia
Site not named
Pärnu, Estonia
Site not named
Tallinn, Estonia
Site not named
Tartu, Estonia
Site not named
Bourges Cedex N/A, France
Site not named
Dole, France
Site not named
Romans-sur-Isère, France
Site not named
Achim, Germany
Site not named
Berlin, Germany
Site not named
Bielefeld, Germany
Site not named
Bochum, Germany
Site not named
Jena, Germany
Site not named
Leipzig, Germany
Site not named
Mannheim, Germany
Site not named
München, Germany
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.